SCHEMBL19110298

SCHEMBL19110298

c1ccc2c(c1)oc1cc(-c3c4ccccc4c(-c4ccc5sc6c7sc8ccccc8c7c7ccccc7c6c5c4)c4ccccc34)ccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN1 P18031 3/20 0.39
▸ AHR P35869 2/20 0.38
▸ MEN1 O00255 4/20 0.37
▸ KMT2A Q03164 4/20 0.37
▸ MAPT P10636 3/20 0.37
▸ KDM4E B2RXH2 3/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ HPGD P15428 3/20 0.37
▸ ESR2 Q92731 2/20 0.36
▸ ESR1 P03372 1/20 0.35
▸ PRKDC P78527 1/20 0.35
▸ HCRTR1 O43613 2/20 0.33
▸ TNKS O95271 1/20 0.33
▸ TNKS2 Q9H2K2 1/20 0.33
▸ PTPRC P08575 1/20 0.33
▸ PTPRF P10586 1/20 0.33
▸ PTPRA P18433 1/20 0.33
▸ PTPRB P23467 1/20 0.33
▸ PTPN6 P29350 1/20 0.33
▸ DUSP3 P51452 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19110300 0.94 AHR (0.35) PTPN1AHRMEN1KMT2AMAPT
SCHEMBL17944898 0.92 AHR (0.38) PTPN1AHRMEN1KMT2AMAPT
SCHEMBL17944945 0.91 AHR (0.37) PTPN1AHRMEN1KMT2AMAPT
SCHEMBL19110314 0.89 AHR (0.35) PTPN1AHRMEN1KMT2AMAPT
SCHEMBL19110093 0.89 ESR2 (0.39) PTPN1AHRMEN1KMT2AMAPT
SCHEMBL17944250 0.89 AHR (0.37) PTPN1AHRMEN1KMT2AMAPT
SCHEMBL17944252 0.89 PRKDC (0.39) PTPN1AHRMEN1KMT2AMAPT
SCHEMBL19110316 0.86 AHR (0.39) PTPN1AHRMEN1KMT2AMAPT
SCHEMBL17945432 0.86 AHR (0.39) PTPN1AHRMEN1KMT2AMAPT
SCHEMBL17247003 0.86 MAPT (0.39) PTPN1AHRMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11276827-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2022-03-15 — — US disclosed
US-20170200905-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-13 — — US disclosed
US-20170200905-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170200905-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 PTPN1 4611/4885AHR 2211/4885MEN1 389/4885
US-11276827-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 PTPN1 4611/4885AHR 2211/4885MEN1 389/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback